|
68
|
276
|
4f1tA |
Crystal structure of the roco4 kinase domain from d. discoideum bound to the rock inhibitor h1152 |
|
88
|
289
|
4hvhA |
Jak3 kinase domain in complex with 2-cyclopropyl-5h-pyrrolo[2,3-b]pyrazine-7-carboxylic acid ((r)-2-hydroxy-1,2-dimethyl-propyl |
|
77
|
302
|
4ez7A |
Cdk2 in complex with staurosporine and 2 molecules of 8-anilino-1-naphthalene sulfonic acid |
|
83
|
287
|
4hvdA |
Jak3 kinase domain in complex with 2-cyclopropyl-5h-pyrrolo[2,3-b]pyrazine-7-carboxylic acid ((s)-1,2,2-trimethyl-propyl)-amide |
|
95
|
359
|
4f7jA |
Crystal structure of human cdk8/cycc in complex with compound 3 (1-[3-tert-butyl-1-(4-methylphenyl)-1h-pyrazol-5-yl]-3-(2-hydroxyethyl)urea) |
|
100
|
356
|
4f9bA |
Human cdc7 kinase in complex with dbf4 and pha767491 |
|
101
|
359
|
4f6wA |
Crystal structure of human cdk8/cycc in complex with compound 1 (n-[3-tert-butyl-1-(4-methylphenyl)-1h-pyrazol-5-yl]-4-[2-({[3-tert-butyl-1-(4-methylphenyl)-1h-pyrazol-5-yl]carbamoyl}amino)ethyl]piperazine-1-carboxamide) |
|
192
|
639
|
4pnkA |
G protein-coupled receptor kinase 2 in complex with gsk180736a |
|
91
|
290
|
4f09A |
Discovery and optimization of c-2 methyl imidazo-pyrrolopyridines as potent and orally bioavailable jak1 inhibitors with selectivity over jak2 |
|
107
|
349
|
4ewqA |
Human p38 alpha mapk in complex with a pyridazine based inhibitor |
|
104
|
326
|
4hvsA |
Crystal structure of kit kinase domain with a small molecule inhibitor, plx647 |
|
112
|
349
|
4f9yA |
Human p38 alpha mapk in complex with a novel and selective small molecule inhibitor |
|
100
|
362
|
4f7nA |
Crystal structure of human cdk8/cycc in complex with compound 11 (1-[3-tert-butyl-1-(4-methylphenyl)-1h-pyrazol-5-yl]-3-(5-hydroxypentyl)urea) |
|
91
|
291
|
4pmpA |
The structure of trka kinase bound to the inhibitor 1-cyclopropyl-1-[3-(1,3-thiazol-2-yl)benzyl]-3-[4-(trifluoromethoxy)phenyl]urea |
|
106
|
348
|
4e5bA |
Structure of p38a map kinase without bog |
|
78
|
298
|
4ek6A |
Crystal structure of the cdk2 in complex with aminopyrazole inhibitor |
|
108
|
351
|
4eh7A |
Human p38 map kinase in complex with np-f6 and rl87 |
|
65
|
282
|
4eqmA |
Structural analysis of staphylococcus aureus serine/threonine kinase pknb |
|
103
|
351
|
4eh5A |
Human p38 map kinase in complex with np-f4 and rl87 |
|
85
|
299
|
4eooA |
Thr 160 phosphorylated cdk2 q131e - human cyclin a3 complex with atp |
|
100
|
335
|
4eklA |
Akt1 with gdc0068 |
|
87
|
291
|
4e1zA |
Structure of mouse tyk-2 complexed to a 3-aminoindazole inhibitor |
|
84
|
299
|
4eoqA |
Thr 160 phosphorylated cdk2 wt - human cyclin a3 complex with atp |
|
105
|
348
|
4e8aA |
The crystal structure of p38a map kinase in complex with pia24 |
|
86
|
298
|
4eokA |
Thr 160 phosphorylated cdk2 h84s, q85m, k89d - human cyclin a3 complex with the inhibitor nu6102 |
|
96
|
298
|
4e6qA |
Jak2 kinase (jh1 domain) triple mutant in complex with compound 12 |
|
86
|
297
|
4ehzA |
The jak1 kinase domain in complex with inhibitor |
|
142
|
650
|
4e3cA |
X-ray crystal structure of human ikk2 in an active conformation |
|
109
|
351
|
4eh2A |
Human p38 map kinase in complex with np-f1 and rl87 |
|
109
|
351
|
4eh3A |
Human p38 map kinase in complex with np-f2 and rl87 |
|
88
|
333
|
4ec8A |
Structure of full length cdk9 in complex with cyclint and drb |
|
87
|
300
|
4eosA |
Thr 160 phosphorylated cdk2 wt - human cyclin a3 complex with the inhibitor ro3306 |
|
89
|
360
|
4e7wA |
Structure of gsk3 from ustilago maydis |
|
81
|
269
|
4enyA |
Crystal structure of pim-1 kinase in complex with (2e,5z)-2-(2-chlorophenylimino)-5-(4-hydroxy-3-methoxybenzylidene)thiazolidin-4-one |
|
106
|
435
|
4ejnA |
Crystal structure of autoinhibited form of akt1 in complex with n-(4-(5-(3-acetamidophenyl)-2-(2-aminopyridin-3-yl)-3h-imidazo[4,5-b]pyridin-3-yl)benzyl)-3-fluorobenzamide |
|
101
|
293
|
4e6dA |
Jak2 kinase (jh1 domain) triple mutant in complex with compound 7 |
|
105
|
351
|
4eh8A |
Human p38 map kinase in complex with np-f7 and rl87 |
|
86
|
300
|
4eojA |
Thr 160 phosphorylated cdk2 h84s, q85m, k89d - human cyclin a3 complex with atp |
|
87
|
321
|
4ec9A |
Crystal structure of full-length cdk9 in complex with cyclin t |
|
107
|
377
|
4e93A |
Crystal structure of human feline sarcoma viral oncogene homologue (v-fes)in complex with tae684 |
|
80
|
298
|
4ek8A |
Crystal structure of the cdk2 in complex with thiazolylpyrimidine inhibitor |
|
92
|
290
|
4e4lA |
Jak1 kinase (jh1 domain) in complex with compound 30 |
|
86
|
296
|
4ek4A |
Crystal structure of the cdk2 in complex with aminopyrazole inhibitor |
|
88
|
290
|
4e20A |
Structure of mouse tyk-2 complexed to a 3-aminoindazole inhibitor |
|
87
|
298
|
4ek5A |
Crystal structure of the cdk2 in complex with aminopyrazole inhibitor |
|
85
|
298
|
4erwA |
Cdk2 in complex with staurosporine |
|
106
|
351
|
4eh4A |
Human p38 map kinase in complex with np-f3 and rl87 |
|
88
|
277
|
4ebvA |
Structure of focal adhesion kinase catalytic domain in complex with novel allosteric inhibitor |
|
95
|
354
|
4e73A |
Crystal structure of jnk1beta-jip in complex with an azaquinolone inhbitor |
|
93
|
298
|
4e4mA |
Jak2 kinase (jh1 domain) in complex with compound 30 |
